Cardiovascular risk in white-coat and sustained hypertensive patients

Blood Pressure

Volumn 11, Issue 6, 2002, Pages 352-356

  Celis, Hilde ^a,b   Staessen, Jan A ^a   Thijs, Lutgarde ^a   Buntinx, Frank ^b   De Buyzere, Marc ^c   Den Hond, Elly ^a   Fagard, Robert H ^a   O'Brien, Eoin T ^d  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d BEAUMONT HOSPITAL   (Ireland)

Author keywords

Ambulatory blood pressure; Cardiovascular risk; Office blood pressure; Sustained hypertension; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ALCOHOLISM; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CIRCADIAN RHYTHM; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WHITE COAT HYPERTENSION;

AGE FACTORS; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 0036931267     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370502321095311     Document Type: Article

References (33)

1. Mallion JM, Baguet JP, Siché JP, Tremel F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999; 17: 585-95.
2. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
3. Verdecchia P. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications. Hypertension 2000; 35: 844-51.
4. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259: 225-8.
5. Owens P, Atkins N, O'Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999; 34: 267-72.
6. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension - a 10-year follow-up study. Circulation 1998; 98: 1892-7.
7. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White coat hypertension. Lancet 1996; 348: 1444-5.
8. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard RF. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomised controlled trial. JAMA 1997; 278: 1065-72.
9. Staessen JA, Amery A, on behalf of the Advisory Board. APTH - A trial on ambulatory blood pressure monitoring and treatment of hypertension: objectives and protocol. Acta Cardiologica 1993; XLVIII: 25-42.
10. Bieniaszewski L, Staessen JA, Polfliet J, Thijs L, Fagard R. Treatment of hypertensive patients according to the conventional or ambulatory pressure: a progress report on the APTH trial. Acta Cardiologica 1996; LI: 243-51.
11. Fagard R, Staessen JA, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation 2000; 102: 1139-44.
12. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB. White-coat hypertension and carotid artery atherosclerosis. A matching study. Arch Intern Med 2000; 160: 1507-12.
13. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1996; 14: 327-32.
14. Soma J, Wideroe TE, Dahl L, Rossvoll O, Skjaerpe T. Left ventricular systolic and diastolic function assessed with two-dimensional and doppler echocardiography in 'white coat' hypertension. J Am Coll Cardiol 1996; 24: 101-5.
15. Staessen JA, Thijs L, Fagard R, et al., for the Systolic Hypertension in Europe Trial Investigators.Predicting cardiovascular risk using conventional vs ambulatory pressure in older patients with systolic hypertension. JAMA 1999; 282: 539-46.
16. Staessen JA, Fagard R, Thijs L, et al., for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
17. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997; 157: 2413-46.
18. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET. Property defining white coat hypertension. Eur Heart J 2002; 23: 106-9.
19. Perloff D, Sokolow M, Cowan RM, Juster RP. Prognostic value of ambulatory blood pressure measurements: further analysis. J Hypertens 1989; 7: S3-10.
20. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-8.
21. Stanton AV. Prediction of cardiovascular damage in hypertensive patients: clinic or ambulatory blood pressures? J Hum Hypertens 1999; 13: 81-3.
22. Khattar RS, Senior R, Swales JD, Lahiri A. Value of intra-arterial blood pressure monitoring in long-term prediction of left ventricular hypertrophy and carotid atherosclerosis in essential hypertension. J Hum Hypertens 1999; 13: 111-6.
23. Ohkubo T, Imai Y, Tsuji I, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15: 357-64.
24. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope M. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998; 31: 712-8.
25. Gosse P, Promax H, Durandet P, Clementy J. White coat hypertension. No harm for the heart. Hypertension 1993; 22: 766-70.
26. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38: 238-45.
27. Pose-Reino A, Rodriguez-Fernandez M, Lopez-Barreiro L, Coleman I-C, Estevez-Nunez JC, Mendez-Naya I. Diagnostic criteria of white-coat hypertension (WCH): consequences for the implications of WCH for target organs. Blood Press 2002; 11: 144-50.
28. Palatini P, Mormino P, Santonastaso M, Mos L, Dal-Follo M, Zanata G, Pessina AC. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31: 57-63.
29. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J 2000; 21: 1714-8.
30. Palatini P, Dorigatti F, Roman E, et al., on behalf of the Harvest Study Investigators. White-coat hypertension: a selection bias? J Hypertens 1998; 16: 977-84.
31. Manning G, Rushton L, Millar-Craig MW. Clinical implications of white coat hypertension: an ambulatory blood pressure monitoring study. J Hum Hypertens 1999; 12: 817-22.
32. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G. Target organ damage, morbidity and mortality. Blood Press Monit 1999; 4: 303-17.
33. Pickering TG, James GD. Ambulatory blood pressure and prognosis. J Hypertens 1994; 12: S29-33.